Literature DB >> 7716709

Systemic lupus erythematosus--disease management.

M F Gourley1.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7716709     DOI： 10.1007/bf00197522

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  81 in total

1.  Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine.

Authors:  T Ruzicka; C Sommerburg; G Goerz; P Kind; H Mensing
Journal:  Br J Dermatol       Date:  1992-11       Impact factor: 9.302

2.  Fluorescent light photosensitivity in patients with systemic lupus erythematosus.

Authors:  M Rihner; H McGrath
Journal:  Arthritis Rheum       Date:  1992-08

Review 3.  Treatment of cutaneous lesions in patients with lupus erythematosus.

Authors:  J P Callen
Journal:  Dermatol Clin       Date:  1990-04       Impact factor: 3.478

4.  Pneumococcal infections in splenectomized children are preventable.

Authors:  H B Konradsen; J Henrichsen
Journal:  Acta Paediatr Scand       Date:  1991-04

5.  The incidence and prognosis of central nervous system disease in systemic lupus erythematosus.

Authors:  J T Sibley; W P Olszynski; W E Decoteau; M B Sundaram
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

6.  Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy.

Authors:  D T Boumpas; H A Austin; E M Vaughan; C H Yarboro; J H Klippel; J E Balow
Journal:  Ann Intern Med       Date:  1993-09-01       Impact factor: 25.391

7.  The comparison of gammaglobulin to steroids in treating adult immune thrombocytopenia. An interim analysis.

Authors:  P Jacobs; L Wood
Journal:  Blut       Date:  1989-07

8.  Effects of oral administration of type II collagen on rheumatoid arthritis.

Authors:  D E Trentham; R A Dynesius-Trentham; E J Orav; D Combitchi; C Lorenzo; K L Sewell; D A Hafler; H L Weiner
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

9.  Splenectomy in systemic lupus erythematosis.

Authors:  J C Gruenberg; E J VanSlyck; J P Abraham
Journal:  Am Surg       Date:  1986-07       Impact factor: 0.688

Review 10.  Immunosuppressive drug therapy for rheumatic disease.

Authors:  W J McCune; A W Friedman
Journal:  Curr Opin Rheumatol       Date:  1993-05       Impact factor: 5.006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.